Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models

Scientific Reports
Micha M M WilhelmusBenjamin Drukarch

Abstract

Alzheimer's disease (AD) is characterised by amyloid-beta (Aβ) protein deposition in the brain. Posttranslational modifications in Aβ play an important role in Aβ deposition. Tissue transglutaminase (tTG) is an enzyme involved in posttranslational cross-linking of proteins. tTG levels and activity are increased in AD brains, and tTG is associated with Aβ deposits and lesion-associated astrocytes in AD cases. Furthermore, Aβ is a substrate of tTG-catalysed cross-linking. To study the role of tTG in Aβ pathology, we compared tTG distribution and activity in both the APPSWE/PS1ΔE9 and APP23 mice models with human AD. Using immunohistochemistry, we found association of both tTG and in situ active tTG with Aβ plaques and vascular Aβ, in early and late stages of Aβ deposition. In addition, tTG staining colocalised with Aβ-associated reactive astrocytes. Thus, alike human AD cases, tTG was associated with Aβ depositions in these AD models. Although, distribution pattern and spatial overlay of both tTG and its activity with Aβ pathology was substantially different from human AD cases, our findings provide evidence for an early role of tTG in Aβ pathology. Yet, species differences should be taken into account when using these models to ...Continue Reading

References

Apr 1, 1991·Neuron·D J Selkoe
Nov 1, 1991·Scientific American·D J Selkoe
Oct 1, 1989·Analytical Biochemistry·W M JeonM K Patterson
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·B SolomonT Katzav
Dec 1, 1996·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·D M AppeltB J Balin
Mar 21, 1997·Brain Research·G V JohnsonR E Powers
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Oct 31, 1998·Nature·M E CalhounM Jucker
Oct 31, 1998·Acta Neuropathologica·W ZhangT D Bjornsson
Jun 11, 1999·The American Journal of Pathology·M StalderM Jucker
Aug 28, 1999·The Journal of Biological Chemistry·D M WalshD B Teplow
May 5, 2001·Biomolecular Engineering·J L JankowskyD R Borchelt
Dec 12, 2001·Neurochemistry International·Dennis J Selkoe
Oct 9, 2002·Trends in Biochemical Sciences·Laszlo Fesus, Mauro Piacentini
Dec 4, 2002·Neurobiology of Disease·Raphael M BonelliGustaf Jirikowski
Dec 10, 2002·Analytical Biochemistry·Mónika SárváriZoltan Nemes
Dec 25, 2002·Neurobiology of Aging·P H KellyB Sommer
Feb 4, 2003·Nature Reviews. Molecular Cell Biology·Laszlo Lorand, Robert M Graham
Jul 25, 2003·Lancet Neurology·Jack van HorssenMarcel M Verbeek
May 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joanna L JankowskyAlena V Savonenko
Jun 10, 2005·FEBS Letters·László Fésüs, Zsuzsa Szondy
Sep 9, 2006·Neuroscience Letters·Ellen VloeberghsPeter Paul De Deyn
Oct 13, 2006·Neurobiology of Disease·Monica Garcia-AllozaMatthew P Frosch
Mar 29, 2007·Amino Acids·R IentileM Griffin
Nov 28, 2007·Annual Review of Pathology·Kenneth L Rock, Hajime Kono
Mar 13, 2008·Journal of Alzheimer's Disease : JAD·Deng-Shun WangDennis W Dickson
Apr 18, 2008·European Journal of Pharmacology·Micha M M WilhelmusBenjamin Drukarch
Jul 16, 2010·Journal of Neural Transmission·Michael T HenekaMarkus Peter Kummer
Sep 18, 2010·Journal of Alzheimer's Disease : JAD·Nienke M TimmerMarcel M Verbeek

❮ Previous
Next ❯

Citations

Jun 9, 2016·Amino Acids·Thung-S LaiCharles S Greenberg
Oct 6, 2021·Expert Opinion on Therapeutic Targets·Jeffrey W Keillor, Gail V W Johnson

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
transgenic

Software Mentioned

Graphpad Prism
SPSS Statistics

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.